Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current management
Neuro-Oncology · 05.01.2024 · 26 (1) · 7-24
DOI: 10.1093/neuonc/noad154 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuro-Oncology, online erschienen am 12.09.2023. Verfasst von Edward K Avila und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Brain Neoplasms, Epilepsy. Die Arbeit wurde bisher 112-mal zitiert (Crossref) und nennt 170 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Tumor-related epilepsy (TRE) is a frequent and major consequence of brain tumors. Management of TRE is required throughout the course of disease and a deep understanding of diagnosis and treatment is key to improving quality of life. Gross total resection is favored from both an oncologic and epilepsy perspective. Shared mechanisms of tumor growth and epilepsy exist, and emerging data will provide better targeted therapy options. Initial treatment with antiseizure medications (ASM) in conjunction with surgery and/or chemoradiotherapy is typical. The first choice of ASM is critical to optimize seizure control and tolerability considering the effects of the tumor itself. These agents carry a potential for drug–drug interactions and therefore knowledge of mechanisms of action and interactions is needed. A review of adverse effects is necessary to guide ASM adjustments and decision-making. This review highlights the essential aspects of diagnosis and treatment of TRE with ASMs, surgery, chemotherapy, and radiotherapy while indicating areas of uncertainty. Future studies should consider the use of a standardized method of seizure tracking and incorporating seizure outcomes as a primary endpoint of tumor treatment trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
- Department of Neurology, VA Boston Healthcare System, Boston, Massachusetts, USA.
- Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
- Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands.
ORCID-Profile: Edward K Avila, Steven Tobochnik, Sara K Inati, Johan A F Koekkoek, Guy M McKhann, James J Riviello, David Schiff, William O Tatum, Jessica W Templer, Michael Weller, Patrick Y Wen
Förderung
- NCI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Avila, E. K., Tobochnik, S., Inati, S. K., Koekkoek, J. A. F., McKhann, G. M., Riviello, J. J., Rudà, R., Schiff, D., Tatum, W. O., Templer, J. W., Weller, M., & Wen, P. Y. (2024). Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current management. Neuro-Oncology, 26(1), 7-24. https://doi.org/10.1093/neuonc/noad154
Vancouver
Avila EK, Tobochnik S, Inati SK, Koekkoek JAF, McKhann GM, Riviello JJ, et al. Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current management. Neuro-Oncology. 2024;26(1):7-24. doi:10.1093/neuonc/noad154
BibTeX
@article{Avila2024,
author = {Avila, Edward K and Tobochnik, Steven and Inati, Sara K and Koekkoek, Johan A F and McKhann, Guy M and Riviello, James J and Rudà, Roberta and Schiff, David and Tatum, William O and Templer, Jessica W and Weller, Michael and Wen, Patrick Y},
title = {Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current management},
journal = {Neuro-Oncology},
year = {2024},
volume = {26},
number = {1},
pages = {7--24},
doi = {10.1093/neuonc/noad154}
}
EUVIMED